Single-use Cystoscope Market Size, Share and Growth Forecast for 2025 - 2032

Single-use Cystoscope Market Outlook (2025 – 2032)

The global single-use cystoscope market size is projected to rise from US$ 104.5 Mn in 2025 to 175.3 Mn in 2032. The market is anticipated to exhibit a considerable CAGR of 8.5% during the forecast period from 2025 to 2032.

Market Size (2025)	US$ 104.5 Million
Projected Market Value (2032)	US$ 175.3 Million
Global Market Growth Rate (2025 – 2032)	8.5% CAGR
Market Share of Top 5 Countries (2024)	58.1%

According to Persistence Market Research, the single-use cystoscope market is experiencing significant growth, driven by increasing demand for minimally invasive procedures, rising prevalence of urological disorders, and advancements in medical technology. Unlike reusable cystoscopes, single-use cystoscopes eliminate the need for sterilization, reduce cross-contamination risks, and offer cost-effectiveness in certain healthcare settings.

Historical Growth and Course Ahead

The single-use cystoscope market has grown steadily in recent years, owing to a greater emphasis on infection control, developments in disposable medical devices, and the rising prevalence of urological illnesses. Historically, the market was quite small, with reusable cystoscopes dominating the business because to their long-term cost savings. However, worries about hospital-acquired infections (HAIs) and the high costs of sterilisation and maintenance have resulted in a trend towards disposable options. Over the last decade, single-use cystoscopes have gained popularity, particularly in outpatient settings and smaller healthcare facilities with limited sterilisation infrastructure.

The market is likely to grow further, owing to technical advancements in visualisation, material durability, and cost efficiency. The expanding use of minimally invasive diagnostic methods, together with the rising incidence of bladder cancer and urinary tract infections, will drive up demand. Furthermore, governmental support for infection control and a preference for single-use medical tools in some locations are projected to promote market growth. Despite obstacles such as cost concerns and competition from reusable alternatives, the estimate predicts a strong expansion of the single-use cystoscope market, particularly in industrialized healthcare systems and emerging economies investing in sophisticated medical infrastructure.

How Can the Global Market Grow?

The rising prevalence of urinary tract conditions such as bladder cancer, urinary strictures, and recurrent urinary tract infections (UTIs) is driving the demand for cystoscopic procedures. Single-use cystoscopes are gaining traction due to their ability to provide high-definition visualization, improved maneuverability, and enhanced diagnostic accuracy without the risk of cross-contamination. As hospitals and urology clinics focus on early disease detection, single-use cystoscopes offer an efficient alternative to reusable counterparts, eliminating the need for complex reprocessing while ensuring sterility.

A recent example highlighting this trend is the increasing adoption of single-use cystoscopes in the U.S. and Europe following the rise in hospital-acquired infections (HAIs).

• In 2023, multiple hospitals in the UK and Germany integrated Ambu’s aScope™ 4 Cysto, a single-use flexible cystoscope, into their diagnostic workflows to minimize infection risks. Studies have shown that disposable cystoscopes can reduce the potential for multidrug-resistant bacterial transmission, a growing concern in healthcare settings.

 Additionally, the increasing geriatric population, which is more susceptible to urological disorders, is further fueling market growth. With advancements in optics and minimally invasive technology, single-use cystoscopes are becoming a preferred choice, widening the scope for early and precise urinary tract diagnostics.

Can the Market Growth Be Affected in Any Way?

“High Per-Procedure Cost Compared to Reusable Cystoscopes”

While single-use cystoscopes eliminate the expenses associated with sterilization, reprocessing, and potential cross-contamination, their higher per-unit cost poses a significant financial challenge for healthcare providers. Hospitals and urology clinics performing a high volume of cystoscopic procedures may find the recurring expenditure on disposable cystoscopes unsustainable compared to reusable models, which, despite requiring cleaning and maintenance, offer long-term cost-effectiveness. In cost-sensitive markets such as India and parts of Latin America, budget constraints in public healthcare systems further restrict the widespread adoption of single-use cystoscopes.

A recent example highlighting this issue is the financial debate surrounding the adoption of disposable cystoscopes in U.S. hospitals in 2023. A study published in Urology Practice analyzed cost differentials and found that single-use cystoscopes, although beneficial in reducing infection risks, increased procedural costs by up to 50% compared to reprocessed reusable alternatives over an annual cycle. The study emphasized that while hospitals with lower procedural volumes could benefit from disposables due to reduced sterilization infrastructure needs, high-volume centers faced significant financial strain. Consequently, many healthcare systems are evaluating hybrid models—reserving single-use cystoscopes for high-risk patients while maintaining reusable devices for standard procedures—to balance cost and infection control priorities.

Country-wise Insights

Why is the U.S. Market Booming?

“Increased Cystoscope Use in Finding Out Curable Causes of Recurrent UTIs”

Recurrent urinary tract infections (UTIs) affect millions of individuals globally, particularly women and older adults, leading to repeated antibiotic treatments and potential complications such as kidney infections. Identifying and addressing curable causes—such as bladder stones, strictures, or tumors—requires detailed visualization of the urinary tract, making cystoscopy a critical diagnostic tool. Traditional reusable cystoscopes, however, pose infection risks due to inadequate reprocessing, leading to an increased shift towards single-use cystoscopes that offer sterility and reduced contamination concerns.

Clinical studies have also highlighted that disposable cystoscopes improve workflow efficiency, allowing for quicker turnaround times in busy urology departments. Additionally, with rising antimicrobial resistance concerns, physicians are emphasizing precise diagnostics over empirical antibiotic use, further boosting demand for single-use cystoscopes. As awareness of curable causes of recurrent UTIs grows, the market for single-use cystoscopes is expected to expand, particularly in regions prioritizing infection control and patient safety in outpatient urology procedures.

Will the U.K. Be a Lucrative Market for Single-use Cystoscope Market?

“High Bladder Cancer Rate and Its High-Cost Need Cystoscope for Cancer Early Detection”

The U.K. market held about 5.6% of the global market share in 2024, and it is anticipated to expand due to the use of cystoscopes for early detection of bladder cancer.

• According to Cancer Research UK, there are 10,300 new bladder cancer cases and 5,555 deaths in the U.K. each year. Bladder cancer has a 50% mortality rate and the highest recurrence rate of any known cancer, reaching up to 80%.
• Cancer Research UK also reports that prostate cancer is the most prevalent cancer in men, with about 47,700 new cases diagnosed each year in the U.K.

In the U.K., bladder cancer treatment is expensive; hence, it is anticipated to expand the global market of single-use cystoscopes for early cancer detection.

Category-wise Insights

Which Type of Product is Driving Demand Within the Global Market?

“More Clinical Utilization of Flexible Video Single-Use Cystoscope Over Other Single-Use Cystoscope”

Flexible video single-use cystoscopes allow urologists and physicians to see the urethra and bladder more clearly due to camera lenses and lower irrigation fluid flow in flexible cystoscopies. Flexible cystoscopy can be performed while the patient is awake. Thus, flexible cystoscopes are patient-friendly, less invasive and easy to use, propelling the flexible single-use cystoscope sector forward.

• According to a published article in the Journal of Endourology in 2022 on the comparison of single-use flexible cystoscope and standard reusable device for bladder cancer surveillance and lower urinary tract symptoms investigation, the single-use flexible cystoscope is superior to standard flexible cystoscope regarding the completion of procedure, and image quality, light quality, and controllability, hence Single-use flexible cystoscopes are a safe and effective alternative.

Which End User is Helping to Expand the Global Market?

“Various Cystoscopy Procedures Need to be done in the Hospitals by Skilled Health Workers”

Cystoscopy is primarily performed in hospitals because trained medical professionals or doctors can remove foreign bodies like bladder stones from the bladder using the proper surgical techniques.

• According to a published article on urolithiasis in the StatPearls of the National Library of Medicines in 2022, urolithiasis is widespread and causes a significantly larger number of hospital admissions.

Other reasons for the use of cystoscopes in hospitals by expertise are to detect bladder cancer, cystitis, and benign prostatic hyperplasia as well as to look into the causes of bladder signs and symptoms, like hematuria, frequent UTIs, incontinence, and dysuria. In order to identify bladder cancer, this method can be used to acquire a biopsy or tissue sample from the bladder lining. Catheter insertion can also be done by cystoscopy (thin drainage tube of urine).

Another reason for expanding hospital end users is the healthcare reimbursement facilities in various countries.

For instance, Medicare has approved the reimbursement policies in the U.S., which allows the payment of US$ 170.28 at the national level for separate procedure of flexible cystoscope with CPT code 52000

Competition Landscape

The key players are concentrating on launching new devices, developing devices that improve efficiency. The key players are primarily focused on new product line innovation and product expansion with partnership of domestic companies for commercialising high quality, cost-effective, disposable endoscopic products.

A few examples of strategies acquired by the key players:

• In October 2024, Ambu announced FDA clearance for its latest cystoscopy solution, the Ambu® aScope™ 5 Cysto HD, in combination with its two full-HD endoscopy systems, Ambu® aView™ 2 Advance and Ambu® aBox™ 2.
• In February 2024, Boston Scientific Corp. recently launched the Versavue single-use flexible cystoscope in the U.S., aiming to reduce the risk of infections in patients caused by the improper reprocessing of reusable cystoscopes.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the single-use cystoscope market, which are available in the full report.

Companies Covered in Single-use Cystoscope Market

• Coloplast Group
• NeoScope Inc.
• Asieris Pharmaceuticals
• Stryker
• Ambu
• Olympus Medical Corporation
• PENTAX Medical
• Richard Wolf GmBH
• Cogentix Medical
• Karl Storz
• Henke-Sass Wolf
• Advanced Health Care Resources
• UroViu Corporation